JP Stock MarketDetailed Quotes

5842 Integral

Watchlist

3985
-70-1.73%

20min DelayTrading Dec 16 13:42 JST

139.38BMarket Cap16.34P/E (Static)

Integral Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Integral Q3 2024 Earnings Date

Currency：JPYNov 11, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	7.70B	--
		+566.69%
EPS	--	129.95	--
		+2584.92%

Analyst Rating

No Data

Integral Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Nov 11, 2024	2024/Q3	7.702B / --	--
May 9, 2024	2024/Q1	5.008B / --	--
Nov 13, 2023	2023/Q3	1.155B / --	--

DatePeriodRevenue/EstimateEarnings Call

Nov 11, 20242024/Q37.702B / ----

May 9, 20242024/Q15.008B / ----

Nov 13, 20232023/Q31.155B / ----

--------

Unlock Free Earnings Estimates

Open Account

Integral Earnings Reports

Integral: (Correction) Partial Corrections to the “Summary Financial Results for the 3rd Quarter of the Fiscal Year Ending 2024/12 [IFRS] (Consolidated)”

Nov 11 21:00 ET

Integral: FY2024Q3 Earnings Presentation

Nov 11 01:30 ET

Integral: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

Nov 11 01:30 ET

Integral: Confirmatory letter.

Aug 13 02:56 ET

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.